With online health and wellness company Hims & Hers opening a new front in the GLP-1 compounding showdown Thursday, the ...

By Anusha Shah and Amina Niasse Feb 7 (Reuters) - Online telehealth company Hims & Hers on Saturday reversed course on its ...

By Carlos Méndez and Chris Thomas Feb 5 (Reuters) - The U.S. Food and Drug Administration (FDA) will take swift action ...

Novo Nordisk has also spoken out strongly against Hims & Hers' compounded Wegovy pill, with CEO Maziar Mike Doustdar telling ...

Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal.

At an employee town hall, FDA leaders tried to quell staff concerns about a controversial new program to fast-track certain ...

The Food and Drug Administration said Thursday that it will not enforce regulations against "false or misleading" material on ...

FDA Commissioner Dr. Marty Makary reveals new guidelines for food packaging labels on products with natural dyes.

Hims & Hers (HIMS) stock drops as FDA warns against illegal copycat drugs while Novo (NVO) threatens action over the ...

Hims & Hers announced they are scrapping plans to sell a compounded version of the weight loss drug Wegovy after federal regulators vowed to take action against the telehealth provider. “Since ...

Feb 5 (Reuters) - The U.S. Food and Drug Administration will take swift action against companies that mass-market "illegal copycat drugs" by claiming they are similar to FDA-approved products, the ...

A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten ...